Cutaneous mastocytosis and allergic diseases in children: A cross-sectional study
- Authors: Kasikhina E.I.1,2, Potekaev N.N.1,3, Ostretsova M.N.2, Zhukova O.V.1,3, Okenaeva A.2, Markovich K.I.1
-
Affiliations:
- Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
- Peoples' Friendship University of Russia
- The Russian National Research Medical University named after N.I. Pirogov
- Issue: Vol 20, No 4 (2023)
- Pages: 429-438
- Section: Original studies
- URL: https://journals.rcsi.science/raj/article/view/253262
- DOI: https://doi.org/10.36691/RJA15044
- ID: 253262
Cite item
Abstract
BACKGROUND: Mastocytosis is a heterogeneous group of diseases characterized by abnormal accumulation of clonal mast cells in one or more organs. Comorbidities in patients with mastocytosis include IgE-dependent allergies, psychiatric or psychological disorders, and vitamin D deficiency. Despite the clinical similarities between allergies and mastocytosis, only a few European studies have considered these comorbidities.
AIM: To analyze the frequency of concomitant-allergic diseases in children with cutaneous mastocytosis.
MATERIALS AND METHODS: Data of 248 children aged 6 months to 17 years who were diagnosed with cutaneous mastocytosis and received outpatient treatment and observation at the Moscow Scientific and Practical Center for Dermatovenereology and Cosmetology between March 2022 and June 2023 were analyzed. Serum levels of total and allergen-specific IgE were analyzed in children with and without allergic diseases. In addition, a positive history of allergy was analyzed in close relatives of children with cutaneous mastocytosis.
RESULTS: Every third child (36.7%) with cutaneous mastocytosis had a concomitant allergic disease. Relatives of 27.4% of the examined children had allergic diseases. The process was significantly more often accompanied by allergic diseases in children with mastocytomas than in those with maculopapular cutaneous mastocytosis (χ2=45.46; p=0.001). The level of total IgE was not a statistically significant sign of the presence of allergic diseases in cutaneous mastocytosis (χ2=1.161; p=0.3). Allergen-specific IgE was detected in 47.2% of the children with allergic diseases. Among children without signs of food allergy and pollinosis, asymptomatic low and moderate sensitization to any plant product and birch was detected in 26.5%. Sensitization to respiratory allergens was found in 8% of children with cutaneous mastocytosis without allergic diseases.
CONCLUSIONS: In Russia, this study demonstrated for the first time a high incidence of allergic diseases in children with cutaneous mastocytosis. The results showed that all clinical forms of mastocytosis in children, including cutaneous mastocytosis, should be subjected to interdisciplinary observation and examination. The timely detection of comorbid allergic diseases contributes to the development of individual techniques for the treatment and prevention of complications and anaphylaxis.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Elena I. Kasikhina
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology; Peoples' Friendship University of Russia
Author for correspondence.
Email: kasprof@bk.ru
ORCID iD: 0000-0002-0767-8821
SPIN-code: 2244-5426
Scopus Author ID: SC15822614300
ResearcherId: HKE-3219-2023
MD, Cand. Sci. (Med.)
Russian Federation, Moscow; MoscowNikolay N. Potekaev
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology; The Russian National Research Medical University named after N.I. Pirogov
Email: klinderma@mail.ru
ORCID iD: 0000-0002-9578-5490
SPIN-code: 8862-5688
MD, Dr. Sci. (Med.), Professor
Russian Federation, Moscow; MoscowMaria N. Ostretsova
Peoples' Friendship University of Russia
Email: ostretsova-mn@rudn.ru
ORCID iD: 0000-0003-3386-1467
SPIN-code: 5767-7621
MD, Cand. Sci. (Med.)
Russian Federation, MoscowOlga V. Zhukova
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology; The Russian National Research Medical University named after N.I. Pirogov
Email: klinderma@inbox.ru
ORCID iD: 0000-0001-5723-6573
SPIN-code: 8584-7564
MD, Dr. Sci. (Med.), Professor
Russian Federation, Moscow; MoscowAizhan Okenaeva
Peoples' Friendship University of Russia
Email: okenaeva61@mail.ru
ORCID iD: 0000-0002-8094-0128
SPIN-code: 9116-2940
Russian Federation, Moscow
Ksenia I. Markovich
Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology
Email: ksenia-markovich@mail.ru
ORCID iD: 0009-0006-1396-2278
Russian Federation, Moscow
References
- Castells M, Metcalfe DD, Escribano L. Diagnosis and treatment of cutaneous mastocytosis in children: Practical recommendations. Am J Clin Dermatol. 2011;12(4):259–270. doi: 10.2165/11588890-000000000-00000
- Valent P, Hartmann K, Schwaab J, et al. Personalized management strategies in mast cell disorders: ECNM-AIM user's guide for daily clinical practice. J Allergy Clin Immunol Pract. 2022;10(8):1999–2012.e6. doi: 10.1016/j.jaip.2022.03.007
- Theoharides TC, Valent P, Akin C. Mast cells, mastocytosis, and related disorders. New Engl J Med. 2015;373 (2):163–172. doi: 10.1056/NEJMra1409760
- Olivera A, Beaven MA, Metcalfe DD. Mast cells signal their importance in health and disease. J Allergy Clin Immunol. 2018;142(2):381–393. doi: 10.1016/j.jaci.2018.01.034
- Matito A, Alvarez-Twose I, Morgado JM, et al. Anaphylaxis as a clinical manifestation of clonal mast cell disorders. Curr Allergy Asthma Rep. 2014;14(8):450. doi: 10.1007/s11882-014-0450-8
- Brockow K, Plata-Nazar K, Lange M, et al. mediator-related symptoms and anaphylaxis in children with mastocytosis. Int J Mol Sci. 2021;22(5):2684. doi: 10.3390/ijms22052684
- Kasikhina EI, Potekaev NN, Kochetkov MA, et al. Mastocytosis: Retrospective analysis of maculopapular cutaneous form. Meditsinskiy sovet. 2023;17(6):180–185. (In Russ). doi: 10.21518/ms2022-005
- Méni C, Bruneau J, Georgin-Lavialle S, et al. Paediatric mastocytosis: A systematic review of 1747 cases. Brit J Dermatol. 2015;172(3):642–651. doi: 10.1111/bjd.13567
- Barnes M, Van L, DeLong L, Lawley LP. Severity of cutaneous findings predict the presence of systemic symptoms in pediatric maculopapular cutaneous mastocytosis. Pediatric Dermatol. 2014;31(3):271–275. doi: 10.1111/pde.12291
- Heinze A, Kuemmet TJ, Chiu YE, Galbraith SS. Longitudinal study of pediatric urticaria pigmentosa. Pediatric Dermatology. 2017;34(2):144–149. doi: 10.1111/pde.13066
- Romantowski J, Górska A, Niedoszytko M, et al. A Challenge for allergologist: Application of allergy diagnostic methods in mast cell disorders. Int J Mol Sci. 2021;22(3):1454. doi: 10.3390/ijms22031454
- Valent P, Akin C, Gleixner KV, et al. Multidisciplinary challenges in mastocytosis and how to address with personalized medicine approaches. Int J Mol Sci. 2019;20(12):2976. doi: 10.3390/ijms20122976
- De Olano DG, Caballer BH, Lopez RN, et al. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: A study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy. 2007;37(10):1547–1555. doi: 10.1111/j.1365-2222.2007.02804.x
- Brockow K, Akin C, Huber M, Metcalfe DD. Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: Relationship to symptomatology, tryptase levels, and bone marrow pathology. Am J Clin Dermatol. 2003;48(4):508–516. doi: 10.1067/mjd.2003.98
- Müller U, Helbling A, Hunziker T, et al. Mastocytosis and atopy: A study of 33 patients with urticaria pigmentosa. Allergy. 1990;45(8):597–603. doi: 10.1111/j.1398-9995.1990.tb00945.x
- González-de-Olano D, Álvarez-Twose I. Insights in anaphylaxis and clonal mast cell disorders. Front Immunol. 2017;(8):792. doi: 10.3389/fimmu.2017.00792
- Dollner R, Taraldsrud E, Iversen K, et al. Non-allergic, mastocytosis-associated rhinitis. Clin Exp Allergy. 2013;43(4):406–412. doi: 10.1111/cea.12053
- Jennings S, Russell N, Jennings B, et al. The mastocytosis society survey on mast cell disorders: Patient experiences and perceptions. J Allergy Clin Immunol Pract. 2014;2(1):70–76. doi: 10.1016/j.jaip.2013.09.004
- Jarkvist J, Brockow K, Gülen T. Low frequency of IgE-mediated food hypersensitivity in mastocytosis. J Allergy Clin Immunol Pract. 2020;8(9):3093–3101. doi: 10.1016/j.jaip.2020.05.044
- Gupta RS, Warren CM, Smith BM, et al. Prevalence and severity of food allergies among US adults. JAMA Netw Open. 2019;2(1):e185630. doi: 10.1001/jamanetworkopen.2018.5630
- Lange M, Niedoszytko M, Renke J, et al. Clinical aspects of paediatric mastocytosis: A review of 101 cases. J Eur Academy Dermatol Venereol. 2013;27(1):97–102. doi: 10.1111/j.1468-3083.2011.04365.x
- Shaffer HC, Parsons DJ, Peden DB, Morrell D. Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: Case report and literature review. J Am Academy Dermatol. 2006;54(5, Suppl):210–213. doi: 10.1016/j.jaad.2005.06.012
- Westwood M, Ramaekers B, Lang S, et al. ImmunoCAP ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: A systematic review and cost analysis. Health Technol Assess. 2016;20(67):1–178. doi: 10.3310/hta20670
- Tontini C, Bulfone-Paus S. Novel approaches in the inhibition of IgE-induced mast cell reactivity in food allergy. Front Immunol. 2021;(12):613461. doi: 10.3389/fimmu.2021.613461
- Müller U, Helbling A, Hunziker T, et al. Mastocytosis and atopy: A study of 33 patients with urticaria pigmentosa. Allergy. 1990;45(8):597–603. doi: 10.1111/j.1398-9995.1990.tb00945.x
- Singh S, Sharma BB, Salvi S, et al. Allergic rhinitis, rhinoconjunctivitis, and eczema: Prevalence and associated factors in children. Clin Respirat J. 2018;12(2):547–556. doi: 10.1111/crj.12561
- Tarczoń I, Cichocka-Jarosz E, Knapp A, Kwinta P. The 2020 update on anaphylaxis in paediatric population. Postepy Dermatol Alergol. 2022;39(1):13–19. doi: 10.5114/ada.2021.103327